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Abstract Host genetics determines the course of Borde-
tella pertussis infection in mice. Previously, we found four
loci, Tlr4 and three novel loci, designated Bps 1–3, that are
involved in the control of B. pertussis infection. The
purpose of the present study was to identify candidate
genes that could explain genetic differences in the course of
B. pertussis infection, assuming that such genes are
differentially regulated upon infection. We, therefore,
studied the course of mRNA expression in the lungs after
B. pertussis infection. Of the 22,000 genes investigated,
1,841 were significantly differentially expressed with 1,182
genes upregulated and 659 genes downregulated. Upregu-
lated genes were involved in immune-related processes,
such as the acute-phase response, antigen presentation,
cytokine production, inflammation, and apoptosis, while
downregulated genes were mainly involved in nonimmune
processes, such as development and muscle contraction.
Pathway analysis revealed the involvement of granulocyte
function, toll-like receptor signaling pathway, and apopto-
sis. Nine of the differentially expressed genes were located
in Bps-1, 13 were located in Bps-2, and 62 were located in
Bps-3. We conclude that B. pertussis infection induces a
wide and complex response, which appears to be partly
specific for B. pertussis a n dp a r t l yn o n s p e c i f i c .W e
envisage that these data will be helpful in identifying
polymorphic genes that affect the susceptibility and course
of B. pertussis infection in humans.
Keywords Bordetella pertussis.Expressionprofiles.
Geneexpression.Immunity.Pathwayanalysis
Introduction
The airway pathogen Bordetella pertussis can cause the
disease known as whooping cough. Despite high vaccina-
tion coverage, pertussis is still an endemic disease with
peaks in incidence every 2–3 years during the last decade
(Crowcroft and Pebody 2006; de Greeff et al. 2003, 2005).
Susceptibility to and severity of B. pertussis infection in
infants and children vary widely (Kimman 2001). The
spectrum of clinical symptoms ranges from subclinical
infection to mild disease, severe whooping cough, and
death. In previous studies, we examined genetic suscepti-
bility of mice to B. pertussis and identified loci in the
mouse genome that are involved in restriction of coloniza-
tion and/or clearance of B. pertussis. We and others have
provided indications for the role of several polymorphic
host genes in the course of B. pertussis infection, including
the interferon gamma receptor (Mahon et al. 1997), toll-like
receptor 4 (Tlr4; Higgins et al. 2003; Mann et al. 2004,
2005), and three putative disease loci, B. pertussis suscep-
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Amsterdam, The Netherlandstibility locus 1, 2, and 3 (Bps-1, 2, and 3; Banus et al.
2005). Tlr4 is a major host factor involved in the course of
B. pertussis infection. C3H/HeJ mice, which carry a
nonfunctional Tlr4 gene, exhibit an aberrant course of
infection. Functional Tlr4 is essential for an efficient IL1-β,
TNF-α, and IFN-γ response, efficient clearance of bacteria
from the lung, and therewith reduced lung pathology
(Banus et al. 2006). The Bps-1 l o c u si sl o c a t e do n
chromosome 12, spanning a region of 185 genes and has
a dominant positive effect on the clearance of B. pertussis
from the lung. The function of most genes in this locus is
unknown. Two other loci, Bps-2 and Bps-3, showed genetic
interaction and are located on chromosomes 5 and 11,
respectively (Banus et al. 2005).
The highest linkage between the number of colony-
forming units (CFU) and the Bps-1 locus that we observed
showed a logarithm of the odds (LOD) score of 4.6. This
LOD score and the corresponding P value (P=0.000025)
are statistically significant also after correction for multiple
comparisons (P=0.0019). We interpreted these data as
suggestive for linkage warranting further investigation
(Banus et al. 2005). In the present study, we aimed to
enhance the insight in the host response and pathogenesis
of B. pertussis infection by identifying genes that are
differentially expressed upon infection. In particular, we
were interested in identifying candidate genes that could
explain genetic differences in the course of B. pertussis
infection, assuming that such genes are differentially
regulated upon infection. For this purpose, we infected
mice and analyzed gene-expression profiles in the lungs on
days 1, 3, and 5 after inoculation using microarrays. We
were especially interested if genes, located in the Bps-1, 2,
and 3 loci, were differentially expressed after B. pertussis
infection or that the susceptibility of these loci was
regulated alternately.
Materials and methods
Experimental design
Female C3H/DISnA mice (eight mice per group, total of
48) were intranasally inoculated with 2×10
7 CFU of the
streptomycin-resistant Tohama strain of B. pertussis (B213)
in 40 μl of Verwey medium (The Netherlands Vaccine
institute, Bilthoven, The Netherlands) or as a control with
Verwey Medium only. One, 3, and 5 days after inoculation,
mice were euthanized. To remove blood cells from the
lungs, mice were perfused with phosphate-buffered saline,
and the lungs and trachea were collected (King et al. 2001;
Willems et al. 1998). For the extraction of RNA, the right
lung was collected in the RNA stabilization reagent
(RNAlater, Qiagen, Venlo, The Netherlands). The left lung
was fixed intratracheally using 4% formalin for histological
examination.
The number of viable B. pertussis bacteria was deter-
mined in the trachea to confirm a proper infection (Verwey
et al. 1949). Therefore, approximately 1 cm of the trachea
was collected in 500 μl of Verwey medium. Bacterial
suspensions were diluted in Verwey medium, and the
number of CFU was determined by plating on Bordet
Gengou agar supplemented with 15% sheep blood and 30
μg/ml streptomycin (Tritium Microbiology, Veldhoven, The
Netherlands). Plates were incubated for 4 days at 35°C
before counting the number of CFUs using a ProtoCOL
Colony counter (Synbiosis, Cambridge, UK).
Animals
Female C3H/DISnA mice were kindly supplied by Dr.
Peter Demant (Department of Molecular and Cellular
Biology, Roswell Park Cancer Institute, Buffalo, NY).
Mice were bred to the appropriate numbers at our animal
testing facility in Bilthoven, The Netherlands. Mice were
acclimatized for at least 1 week before the start of the
experiments. Mice received standard laboratory food
(SRM-A, Hope Farms, Woerden, The Netherlands) and
tap water ad libitum. All animal experiments were approved
by the Institute’s Animal Ethics Committee and were
performed according to the National Institutes of Health
(1996) guidelines.
Clinical and pathological examinations
Mice were weighed before inoculation and subsequently
every day after inoculation to determine the relative change
in weight. Lung weights were determined postmortem as a
parameter for lung inflammation. Formalin-fixed lungs were
embedded in paraplast (Monoject, St Louis, MO). Sections
(5 μm) were stained with hematoxylin eosin. Lung lesions
were examined for infiltration of inflammatory cells in the
peribronchiolar space (peribronchiolitis), infiltration of
inflammatory cells in the alveoli (alveolitis), infiltration of
inflammatory cells in the perivascular space (perivasculitis),
hypertrophy of mucus-producing glands, free protein (exu-
date), and eosinophilia. Lung lesions were scored semiquan-
titatively as absent, minimal, slight, moderate, marked, or
strong as previously described (Barends et al. 2004).
Transcription profiling
Lungs were incubated in RNAlater (Qiagen) at 4°C for 1
day, after which, the tissues were transferred to a fresh tube
and stored at −80°C. RNA was extracted by using the midi-
RNA isolation kit (Qiagen). RNA concentrations were
measured using a NanoDrop Spectrophotometer (Nano-
556 Immunogenetics (2007) 59:555–564Drop Technologies, Wilmington, DE). RNA quality was
determined using the 2100 Bioanalyzer (Agilent Technol-
ogies, Santa Clara, CA) and was expressed as the RNA
Integrity Number (RIN) as defined by the manufacturer.
Only samples with a RIN score of at least eight (on a 1–10
scale) were used for expression profiling.
Microarray slides were spotted at the Microarray De-
partment of the University of Amsterdam. The slides contain
21,997 65-mer oligo nucleotides from the Sigma-Compugen
Mouse oligonucleotide library, 192 additional 65-mer oligo
nucleotides of genes, of which 185 were located in the Bps-1
region spotted in duplicate (Isogen Life science, IJsselstein,
The Netherlands), as well as appropriate controls and blank
spots.
Based on RNA quality and yield, RNA isolated from six
mice per group was selected for amplification and labeling.
RNA amplification and labeling were carried out using the
Amino Allyl MessageAmp II aRNA kit (Ambion, Austin,
TX) using 1 μg of total RNA as starting material. RNA
samples from individual mice were labeled with Cy3. A
common reference containing a RNA pool of all samples
isolated was labeled with Cy5. After hybridization and
washing, the arrays were scanned using a ScanArray
4000XL microarray scanner (Perkin-Elmer, Wellesley, MA).
Median Cy3 and Cy5 spot signals were determined
using ArrayVision (Imaging Research, St. Catharines, ON,
Canada). Quality control was performed by means of visual
inspection of the scanned images, raw data scatter, and MA
plots (M is a mnemonic for the log-ratios of expression, A
is a mnemonic for the log-intensity of each spot; Smyth and
Speed 2003), as well as a normal probability plot to assess
signal distribution (Pennings and Heisterkamp 2004). If
more than 10% of the spots were flagged as missing data,
slides were excluded from data analysis. At least five slides
per group were used for further analysis.
Raw microarray signal data were normalized in the R
statistical software environment (R Development Core
Team 2005) using a four-step approach of (1) natural log
transformation, (2) quantile normalization of all scans, (3)
correcting for differences in the reference signal, and (4)
averaging replicate spot data.
Significance of differences in gene expression between the
experimental groups was calculated in R with analysis of
variance. The false discovery rate (FDR) was calculated
according to Benjamini and Hochberg (1995). The FDR is
the expected proportion of false positives among the genes
considered significantly differentially expressed (Benjamini et
al. 2001; Benjamini and Hochberg 1995). Gene-expression
data were visualized by hierarchical clustering (using
Euclidian distance and Ward linkage) using GeneMaths
(Applied Maths, St-Martens-Latem, Belgium). For this pur-
pose, gene-expression values were corrected for the overall
average to allow a neutralcomparison between all B. pertussis-
and mock-inoculated groups. Gene categories were defined
by Gene Ontology (GO, http://www.geneontology.org). Clas-
sification and enrichment according to GO categories were
determined using DAVID/EASE (Dennis et al. 2003;H o s a c k
et al. 2003), using EASE scores as P values for enrichment.
Additional pathway analysis was performed using Meta-
Core™ (GeneGo, http://www.genego.com).
Results
Bacteriologic and pathologic findings
All B. pertussis-inoculated mice had between 10
2 and 10
5
CFUs in the trachea during the first 5 days after inoculation
thereby confirming a proper infection. A statistically
significant decrease in the number of bacteria in the trachea
was observed over time during the first 5 days postinocu-
lation (P=0.022, linear regression, SPSS, data not shown).
Infected mice lost up to 4% of their body weight during
the first 5 days postinoculation, while all mock-inoculated
mice gained weight up to 4% during these 5 days. This
difference in relative gain of weight between mock- and B.
pertussis-inoculated mice is significant from day 1 to 5
postinoculation (Supplementary data Figure 2).
We determined lung weights in relation to body weight as
a marker for inflammation. All mock-inoculated mice had
relative lung weights of approximately 1% during the first 5
days after inoculation, while B. pertussis-infected mice had
relative lung weights of up to 3% of their total body
weight. This difference in relative lung weights between
mock- and B. pertussis-inoculated mice is significant from
day 1 to 5 postinoculation (Supplementary data Figure 3).
A summary of histopathological findings is presented in
Table 1. Intranasal inoculation of B. pertussis causes an
acute inflammatory response that is characterized by influx
of polymorphonuclear leukocytes (PMNs) and macro-
phages starting in perivascular and peribronchiolar areas
on day 1 and extending to alveolar walls and lumina on
days 3 and 5.
Expression profiling
Gene-expression profiles were determined in at least five
animals per group. The three mock-inoculated groups,
euthanized at days 1, 3, and 5, were statistically indistin-
guishable (i.e., there were no genes with FDR<0.6). Of the
approximately 22,000 genes tested, 1,841 genes were
significantly differentially expressed in B. pertussis-inocu-
lated lungs (FDR<0.05, corresponding to P<0.0042).
Expression levels of all 1,841 genes as well as compar-
isons to other studies are presented in the supplementary
data Table 5.
Immunogenetics (2007) 59:555–564 557Hierarchical clustering showed time-dependent changes
in gene expression with 1,182 upregulated genes and 659
downregulated genes. Of these genes, 439 were more than
twofold upregulated, and 134 were more than twofold
repressed. All genes followed a similar trend in time. One
day postinoculation differential gene expression was
already observed, but the effect was larger on days 3 and
5 postinoculation (Fig. 1). There was no identifiable subset
of genes that displayed a different kinetic trend in gene
expression.
To assign functions to differentially expressed genes, we
classified them according to GO categories. In addition, we
determined enrichment for GO categories to identify
pathophysiological processes involved in response to B.
pertussis. The most important GO categories, i.e., with the
highest percentage differentially expressed genes, are
summarized in Table 2. Most upregulated genes are
involved in immune response-related processes, such as
the acute phase response, antigen presentation, cytokine
activity, inflammation, and apoptosis; whereas downregu-
lated genes are involved in nonimmune processes, such as
development, muscle contraction, cytoskeleton, and general
processes like metabolism.
To reveal intergene relationships, we performed Meta-
Core™ analysis on the 1,841 regulated genes in addition to
the GO-basedanalysispresented above. The most significant
pathways are presented in Table 3. This analysis revealed
the significance of several pathways, such as regulation of
granulocyte function, the toll-like receptor (TLR) signaling
pathway, the classic complement pathway, and apoptosis.
Table 1 Histological evaluation of lung changes after B. pertussis inoculation
Parameter and grade No. of animals
a
Mock B. pertussis
Day 1 Day 3 Day 5 Day 1 Day 3 Day 5
Peribrochiolitis
b Minimal 2 3 4 2 2
Slight 1 2 5
Moderate 3
Total
c (25%) (0%) (38%) (63%) (88%) (88%)
Perivasculitis Minimal 2 2 2 2 1
Slight 4 3 3
Moderate 35
Marked 1
Total (25%) (25%) (25%) (75%) (100%) (100%)
Hypertrophy Minimal 1 1 1 2
Slight 1
Moderate 31
Marked 24
Strong 1
Total (13%) (0%) (13%) (13%) (88%) (88%)
Alveolitis Minimal 21
Slight 4 2
Moderate 31
Marked 13
Strong 31
Total (0%) (0%) (0%) (75%) (100%) (88%)
Exudate Minimal 22
Slight 22
Moderate 11
Marked 1
Strong 1
Total (0%) (0%) (0%) (0%) (100%) (63%)
aEight mice per group were inoculated with medium (mock) or B. pertussis.
bHematoxylin/eosin-stained slides were examined for peribronchiolitis, alveolitis, perivasculitis, hypertrophy of mucus-producing glands, and free
protein (exudate). Lung lesions were scored semiquantitatively as absent (not included in table), minimal, slight, moderate, marked, or strong.
cTotal percentage of animals with at least minimal scoring in the specified category
558 Immunogenetics (2007) 59:555–564Table 2 Classification of genes induced upon B. pertussis infection
a
Up Down
b Total on array P value
c
Acute-phase response
d 12 (55%) 0 (0%) 22 2.4×10
−7 (up)
Antigen presentation 21 (66%) 0 (0%) 32 7.7×10
−15 (up)
Apoptosis 47 (15%) 6 (2%) 324 8.0×10
−5 (up)
Cell cycle 43 (8%) 22 (4%) 510 4.3×10
−1 (up)
Chemokine activity 21 (58%) 0 (0%) 36 1.2×10
−13 (up)
Complement activation 8 (26%) 1 (3%) 31 9.7×10
−3 (up)
Cytokine activity 48 (25%) 6 (3%) 192 7.8×10
−13 (up)
Cytoskeleton 31 (6%) 40 (8%) 531 2.0×10
−3 (down)
Development 96 (7%) 94 (7%) 1,433 9.8×10
−1 (down)
Immune response 162 (40%) 3 (1%) 408 6.3×10
−75 (up)
Inflammatory response 46 (38%) 2 (2%) 121 1.1×10
−19 (up)
Metabolism 353 (7%) 220 (5%) 4,771 1.8×10
−1 (down)
Muscle contraction 0 (0%) 12 (24%) 49 6.7×10
−6 (down)
Listed in any of the above 576 (9%) 318 (5%) 6,574
Other 328 (6%) 204 (4%) 5,639
Unannotated 278 (3%) 137 (1%) 9,744
Total 1,182 (5%) 659 (3%) 21,957
aClassification according to gene-ontology (GO) categories
bAnalysis was performed on 1,841 regulated genes.
cEase score for GO category enrichment in the specified set of genes
dSome genes are classified into multiple categories.
a                           b
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Fig. 1 Presentation of microarray data from mock- and B. pertussis-
inoculated mice. Analysis was performed on 1,841 genes whose
expression was found to be significant at an FDR<0.05. a Hierarchical
clustering shows the segmentation of the genes clustered by gene
expression. Relatively increased gene expression is presented in red,
while relatively decreased gene expression is presented in green. The
color scale shows log(2) ratios of gene expression levels compared to
the global average. b Course of B. pertussis-regulated gene expression;
diamonds represent the average of 1,182 upregulated genes, and
squares represent the average of 659 downregulated genes. Error bars
show the standard deviation (SD) of the average gene expression
Immunogenetics (2007) 59:555–564 559Genes located in Bps-1 that were differentially regulated
upon B. pertussis inoculation and their function according
to the GO database are presented in Table 4. Bps-1 contains
185 genes, of which nine were differentially expressed. The
strongest upregulated genes in this locus were trypto-
phanyl-tRNA synthetase (Wars, fourfold) and tumor necro-
sis factor alpha-induced protein 2 (Tnfaip2, 5.4-fold). Zinc
finger FYVE domain containing 21 (Zfyve21, 1.5-fold) and
kinesin family member 26A (Kif26a, 1.7-fold) were the
strongest downregulated genes.
Genes located in Bps-2 and -3 that were differentially
regulated upon B. pertussis inoculation are presented in
Supplementary data Table 6. Bps-2 is located on chromo-
some 5 and contains 262 genes, of which 13 were
differentially expressed. Interleukin-6 (IL-6) was the stron-
gest upregulated gene (4.7-fold) in this locus, and general
transcription factor IIIC, polypeptide 2, beta was the
strongest downregulated gene (twofold) in this locus. Bps-3
is located on chromosome 11 and contains 922 genes, of
which 62 were differentially expressed. Chemokine (C–C
motif) ligand 8 was the strongest upregulated gene (15.3-
fold) in this locus, and RIKEN cDNA 9530033F24 gene was
the strongest downregulated gene (2.3-fold) in this locus.
Discussion
We have recently shown that genetic differences of the
host play an important role in the restriction of
colonization and/or clearance of B. pertussis from the
lungs of mice (Banus et al. 2005, 2006). In the present
study, we wanted to extend the understanding of the host
response to B. pertussis and identify genes and pathways
that play a role in the pathophysiological response to B.
pertussis infection. In particular, we were interested in
identifying candidate genes that could explain genetic
differences in the course of B. pertussis infection, assuming
that such genes are differentially regulated upon infection.
For these purposes, we studied the time course of mRNA-
expression in the lungs of mice after a B. pertussis infection
by microarray analysis. We were especially interested if
genes, located in the Bps-1, 2,a n d3 loci, were differen-
tially expressed after B. pertussis infection or that the
susceptibility conferred by these loci was regulated
alternately.
Of the approximately 22,000 genes investigated, we
found 1,841 (8.4%) genes to be significantly differentially
expressed. Differential gene expression was already ob-
Table 3 Pathway analysis of genes induced upon B. pertussis infection
Name of Pathway involved
a Main process P value No. of genes in pathway
Expressed Total
Transcription regulation of granulocyte development Immune response 0.000001925 17 (38%) 45
TLR ligands and common TLR signalling pathway Immune response 0.00001814 16 (34%) 47
ECM remodeling Metabolism 0.00003906 18 (30%) 60
Role of IAP proteins in apoptosis Apoptosis 0.00005458 13 (36%) 36
HETE and HPETE diosynthesis and metabolism Metabolism 0.0003249 13 (31%) 42
TPO signaling via JAK-STAT pathway Cell cycle 0.0003893 9 (39%) 23
Leukotriene 4 biosynthesis and metabolism Metabolism 0.0004655 16 (27%) 60
RhoA regulation pathway (extension, GEFs/GAPs) Immune response 0.002412 10 (29%) 34
MIF in innate immunity response Immune response 0.002435 14 (25%) 57
Retinol metabolism Metabolism 0.002842 12 (26%) 46
Classic complement pathway Complement activation 0.002842 12 (26%) 46
Putative erythropoietin signaling pathway (part 1) Immune response 0.002905 13 (25%) 52
MAPK cascade Cell cycle 0.004975 12 (24%) 49
Ceramide-dependent NO antiapoptotic action Apoptosis 0.006738 13 (23%) 57
IL9 signaling pathway Cytokine activity 0.006809 9 (27%) 33
Ephrins signaling Other 0.007847 13 (22%) 58
Polyamine metabolism Metabolism 0.008731 7 (30%) 23
Integrin outside-in signaling Cell cycle 0.009444 16 (20%) 79
Chemokines and adhesion Chemokine activity 0.009657 34 (16%) 209
Analysis was performed on 1,841 genes whose expression was found to be significant at an FDR<0.05. The list is presented by descending P
values. P values represent the probability of particular mapping arising by chance given the numbers of genes in all Metacore pathways, genes
involved in the specified pathway, and genes regulated upon B. pertussis inoculation.
ECM Extracellular matrix, GAP GTPase-accelerating protein, GEF guanine nucleotide exchange factor, HPETE hydroperoxyeicosatetraenoic
acid, HETE hydroxyeicosatetraenoic acid, IAP inhibitor of apoptosis, IL9 interleukin 9, JAK Janus tyrosine kinase, MIF macrophage migration
inhibitory factor, MAPK mitogen-activated protein kinase, NO nitric oxide, RhoA ras homolog gene family member A, STAT signal transducers
and activators of transcription
aClassification according to main gene-ontology (GO) categories
560 Immunogenetics (2007) 59:555–564served on day 1 postinoculation, but the maximum effect
was observed on day 3 postinoculation. This effect
remained constant till at least day 5 postinoculation. The
observed course in gene expression after B. pertussis
inoculation was similar to that induced by another gram-
negative lung pathogen, Francisella tularensis (Andersson
et al. 2006).In a study of expression profiles in the lungs of
F. tularensis-infected C57BL/6 mice, 424 (2.3%) genes out
of the 18,500 genes investigated were upregulated. Genes
involved in immune responses were activated strongly on
day 4 postinoculation but hardly or not at all on days 1 and
2 (Andersson et al. 2006).
As expected, most upregulated genes are involved in
immune and inflammation-related processes, such as
antigen presentation, complement, cytokine, and chemokine
activity. Other processes involved include the acute phase
response and metabolism. Most downregulated genes are
involved in nonimmune processes, such as metabolism,
development, cell cycle, or muscle contraction. We specu-
late that by downregulating these genes, the energy balance
is shifted in favor of the immune response. Evidently,
cellular influx in the lungs is likely to influence the gene-
expression profile.
Our data provide more detailed information on the
central role of PMNs in the pathogenesis of B. pertussis
infection. Pathogenesis of B. pertussis infection is charac-
terized by colonization and proliferation of the ciliated
mucosal cells resulting in damage of the respiratory
epithelium and an acute increase in the levels of inflam-
matory cytokines resulting in cellular infiltrate in the
alveolar spaces (Mattoo and Cherry 2005; Mills 2001;
Preston 2005). Circulating PMNs are rapidly recruited to
the lungs to bind and ingest B. pertussis, subsequently
killing the bacteria by a combination of reactive oxygen
and granule components. Finally, the PMNs undergo
apoptosis (Kobayashi et al. 2005a). TLR ligands such as
lipopolysaccharides (LPS) are critical components for the
recruitment and priming of PMNs. Serum antibody-medi-
ated clearance of B. pertussis also requires a TLR-induced
early recruitment of PMNs. However, pertussis toxin limits
this rapid serum antibody-mediated clearance by inhibiting
PMN recruitment (Kirimanjeswara et al. 2005). As deter-
mined by pathway analysis in this study, the most
significant pathways involved in the response to B.
pertussis infection are regulation of PMN function, TLR
signaling pathway, extracellular matrix remodeling, and
apoptosis. It has been described that apoptosis of PMNs, in
which TLR2 plays an important role (Jablonska et al.
2006), is accelerated after phagocytosis of bacteria
(Kobayashi et al. 2005a, b). Therefore, the involvement
of three out of four pathways may, at least partly, be
explained by the influx of PMNs. Our data thus further
illustrate the central role of PMNs in the course of B.
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function.
We found the response to B. pertussis to be wide and
complex. Some remarkable findings were the involvement
of mucin genes, intracellular pathogen resistance gene, and
the excessive upregulation of serum amyloid A (SAA)
genes. We found the mucin (Muc) genes Muc4 and Muc5b
to be significantly upregulated. Expression of mucin in the
respiratory tract is one important innate host defense
mechanism that respiratory pathogens must overcome
(Belcher et al. 2000). Muc4, which encodes a respiratory
tract mucin glycoprotein, was expressed 3.3-fold at day 5
upon B. pertussis inoculation. Muc5b, which encodes
mucin 5, subtype B protein, in tracheobronchial epithelial
cells, was expressed 1.8-fold 3 days upon inoculation.
Belcher et al. (2000) described that B. pertussis induces
mucin gene transcription by BEAS-2B cells. Evidently,
gene expression studies do not allow to define the
functional role of regulated genes. Further studies should
define whether the mucin response is favorable to the host,
the pathogen, or both.
In our study, we found a threefold upregulation of the
intracellular pathogen resistance gene 1 (Ipr1). Ipr1
mediates innate immunity to mycobacterium tuberculosis
(Pan et al. 2005). Pan et al. (2005) speculated that the Ipr1
gene product might function in integrating signals generat-
ed by intracellular pathogens with mechanisms controlling
innate immunity, cell death, and pathogenesis. Our data
therefore suggest that Ipr1 may be involved in intracellular
presence of B. pertussis. Interestingly, B. pertussis was
shown to survive intracellularly in macrophages, PMNs and
bronchoalveolar lavage (BAL) cells of mice (Hellwig et al.
1999; Mills 2001).
Among the upregulated genes upon B. pertussis inocu-
lation, SAA genes were upregulated to a remarkably high
extent. SAA is an acute phase protein whose expression is
markedly upregulated during inflammation and infection
(Uhlar and Whitehead 1999). Among other functions, this
protein plays an important role in high density lipoprotein
cholesterol metabolism by promoting cellular cholesterol
efflux through a number of different efflux pathways (van
der Westhuyzen et al. 2005). In our study, SAA1, 2, and 3
were induced 14-, 54-, and 44-fold, respectively, after B.
pertussis infection, again underlining the important role for
the acute phase response after B. pertussis infection.
Although strongly upregulated, it is clear that the acute-
phase response is not specific for B. pertussis infection.
In a previous study, we observed a 1.5-fold upregulation
of the membrane-receptor Tlr4 and a fivefold upregulation
of the downstream cytokine gene Tnf-α 3 days post-B.
pertussis inoculation by means of quantitative real-time
polymerase chain reaction (PCR). Thus, a slight upregula-
tion (1.5-fold) of this receptor induces a more pronounced
(fivefold) induction of this downstream proinflammatory
cytokine (Banus et al. 2006). In the present study, we
obtained similar results by using microarray analysis. Tlr4
expression was increased 1.6-fold, while the expression of
Tnfaip was increased 4.5-fold 3 days postinoculation. The
results of the present study hereby confirm our previous
observations. In a recent study, a high correlation between
gene-expression values determined by quantitative real-
time PCR and microarray was observed (Canales et al.
2006). Given these results and our observations, we
conclude that the results, at least for the two given genes,
are similar for both techniques.
It is very likely that the expression profile to B. pertussis is
partly unique to B. pertussis and partly nonspecific. To
examine the specificity of B. pertussis-regulated gene
expression, we compared our data to other studies. In a
recent review by Jenner and Young (2005), a comparison
was made between published transcriptional profiling data
from 32 studies that involved 77 different host–pathogen
interactions. A set of 417 genes that comprise a common
host transcriptional response was defined. We found that 122
genes affected by B. pertussis infection were listed in this
common host–pathogen response, further illustrating that
many genes regulated by B. pertussis are indeed not specific
for B. pertussis infection but are involved in a common
response to pathogens. One explanation for the broad
response in expression profiles is the complexity of the
bacterium. It is, for instance, known that LPS is a very
potent immune stimulus, which induces a strong inflamma-
tory response (Kawai et al. 2001; Qin et al. 2005; Wells et al.
2003). Transcriptional profiling of LPS-induced acute lung
injury in mice resulted in 71 immune-related upregulated
genes (Jeyaseelan et al. 2004). Of these 71 genes, 43 were
also regulated upon B. pertussis inoculation in this study.
Previously, we have demonstrated that the Bps-1 locus
has a dominant positive effect on the clearance of B.
pertussis from the lung. Of the 185 genes in this locus, nine
were differentially expressed. Some of these genes could
explain the linkage of this locus with susceptibility to B.
pertussis infection. Tumor necrosis factor, alpha-induced
protein 2 (Tnfaip2), has been described as a tumor necrosis
factor-alpha-inducible primary response gene in endothelial
cells (Sarma et al. 1992). Aminoacyl-tRNA synthetases
catalyze the aminoacylation of tRNA with their cognate
amino acid. Tryptophanyl-tRNA synthetase (Wars) cata-
lyzes the aminoacylation of tRNA(trp) with tryptophan and
is induced by interferon (Ibba and Soll 2000).The role of
the nine genes in the B. pertussis infection process is
unknown and will be investigated in future experiments.
Thus, by using a microarray approach, we selected nine
possible candidate genes from the 185 present in Bps-1.
However, by this approach, we focused on transcriptionally
regulated genes, and the possibility remains that suscepti-
562 Immunogenetics (2007) 59:555–564bility to B. pertussis is regulated in a different way, such as
phosphorylation or protein binding.
In comparison to the Bps-1 region, the Bps-2 and -3
regions contain considerably more genes, namely, 262 and
922 genes, respectively, of which 13 and 62 were
differentially expressed post-B. pertussis inoculation.
Among these differentially expressed genes are several
interesting candidate genes that may explain the linkage of
these loci with susceptibility to B. pertussis infection. IL-6
was the most strongly induced gene in the Bps-2 region
(4.7-fold). IL-6 is a proinflammatory cytokine that can be
secreted by macrophages after Tlr4 activation (Akira and
Takeda 2004). Among the genes differentially expressed in
the Bps-3 region was a large group of chemokines, of
which Chemokine (C–C motif) ligand 8 was the strongest
upregulated gene (15.3-fold). Upon B. pertussis infection,
this large group of chemokines is induced to promote
immune cells to migrate to the site of infection. The role of
the other B. pertussis-induced genes in these loci is still
unknown and will be investigated in future experiments.
In conclusion, we found 1,841 genes in the lungs of
mice that are differentially expressed after B. pertussis
inoculation. Most upregulated genes are involved in
immune and inflammation-related processes or in nonspe-
cific processes. Most downregulated genes are involved in
nonimmune processes. A substantial number of genes and
pathways provide more detailed information on the central
role of PMNs in the pathogenesis of B. pertussis.I n
particular, the transcriptional profiles indicate the signifi-
cance of genes involved in TLR activation, the recruitment
and activation of PMNs, and apoptosis.
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